From the labto the hospital

Thoracic Tumours and Head and Neck Cancer

Grup de tumors toràcics i càncer de cap i coll a Vall d'Hebron

The Thoracic  Tumours and Head and Neck Cancer group is contributing to the development of suitable drugs and therapies for thoracic tumours, as well as head and neck tumours. Through translational research, they are getting closer to advanced personalised medicine for patients with lung cancer. At the same time, the group is optimising new approaches to treatments for patients with malignant thoracic, head and neck tumours.

Description

The group is currently focusing on putting into practice ALK translocation, studying how effective PI3K/mTOR inhibitors are in patients with EGFR-TKI-resistant lung cancer, and studying how effective PARP inhibitors are in lung cancer.

They are analysing the epidemiological and clinical characteristics of women diagnosed with lung cancer. They are committed to reinforcing a multidisciplinary approach to provide the best care for patients, and are proactive in the fight against smoking.

Visit the research group’s page

Healthcare specialisations
Teaching units
  
Noticies y activitats relacionades